Bone Remodelling

Blair H. , Teitelbaum S. , Ghiselli R. and Gluck S. (1989) Osteoclastic bone resorption by a polarised vacuolar proton pump, Science, 245, 855–857.

Canons E. (1983) The hormonal and local control of bone formation, Endocrine Reviews, 4, 62–77.

Charles P. , Ericksen E.F. , Mosekilde L. , Melsen F. and Jensen F.T . (1987) Bone turnover and balance evaluated by a combined calcium balance and 47calcium kinetic study and dynamic histomorphometry, Metabolism: Clinical and Experimental, 36, 1118–1124.

Drake F.H. , Robert A.D. , James I.E. , Conner J.R. , Debouck C.C. , Richardson S. , Lee-Rykaczewski E. , Coleman L. , Rieman D. , Barthlow R. , Hastings G. and Gowen M. (1996) Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts, Journal of Biological Chemistry, 269, 15006-15009.

Ericksen E. , Mosekilde L. and Melsen F. (1986) Trabecular bone remodelling and balance in primary hyperparathyroidism, Bone, 7, 213–221.

Fuller K. , Gallagher A. C. and Chambers T. J. (1991) Osteoclast resorption-stimulating activity is associated with osteoblast surface and/or extra cellular matrix, Biochemical and Biophysical Research Communications, 181, 67–73.

Frost H.M . (1964) Dynamics of bone remodelling, In: Bone Biodynamics, Frost H. M. (ed.), pp.315-333, Little Brown, Boston.

Frost H. (1991) A new direction for osteoporosis research: a review and proposal, Bone, 12, 429–437.

Gay C. and Mueller W. (1974) Carbonic anhydrase and osteoclasts: locali7ation by labelled autoradiography, Science, 183, 432–434.

Hattersley G. , Kerby J. and Chambers T. (1991) Generation of osteoclast precursors in multilineage hemopoietic colonies, Endocrinology, 128, 259–262.

Hill P. A. , Reynolds J. J. and Meilde M. C. (1993) Inhibition of stimulated bone resoprtion in vitro by TIMP-1 and TIMP-2, Biochemica et Biophysica Acta, 1177, 71–74.

Hill P. A. , Buttle D. , Jones S. , Boyde A. , Murata M. , Reynolds J. J. and Meikle M. C. (1994a) Inhibition of bone resorption by selective inactivators of cysteine proteinases, Journal of Cellular Biochemistry, 56, 118–130.

Hill P. A. , Murphy J. , Docherty A. , Hembry R. , Millican T. , Reynolds J. J. and Meikle M. C. (1994b) The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resoprtion and the identification of MIMPs and TIMP-1 in isolated osteoclasts, Journal of Cell Science, 107, 3055–3064.

Hill P. A. , Docherty A. , Bottomley K. , O'Connell J. P. , Morphy J. R. Reynolds J. and Meikle M. C. (1995) Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase, Biochemical Journal, 308, 167–175.

Hill P. A. , Tumber A. and Meikle M. C. (1997) Multiple extracellular signals promote osteoblast survival and apoptosis, Endocrinology, 138, 3849–3858.

Laitala T. and Vaananen H. K. (1994) Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase, Journal of Clinical Investigation, 93, 2311–2318.

Lakkakorpi P. , Horton M. , Helfrich M. , Karhukorp E. and Vaananen H. K. (1991) Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface, Journal of Cell Biology, 115, 1179–1186.

Lean J. M. , Mackay A. , Chow J. and Chambers T. (1996) Osteocytic expression of mFtNA for c-fos and IGF-I; an immediate early gene response to an osteogenic stimulus, American Journal of Physiology, 270, 937–945.

Lewis D. B. , Liggitt H. D. , Effmann E. L ., motley, S. T., Teitelbaum, S. L., Jepsen, K. J., Goldstein, S. A., Bonadio, J., Carpenter, J. and Permutter, R. M. (1993) Osteporosis induced in mice by overproduction of interleukin-4, Proceedings of the National Academy of Science U.S.A., 90, 11618–11622.

Manolagas S. C. and Jilka R. (1995) Bone marrow, cytokines, and bone remodelling. Emerging insights into the pathophysiology of osteoporosis, New England Journal of Medicine, 232, 305–311.

Martin T. J. and Ng K. (1994) Mechanisms by which cells of the osteoblast lineage control osteoclast formation and function, Journal of Cellular Biochemistry, 56, 357–366.

Massague J. (1985) Transforming growth factor beta modulates the high affinity receptors of epidermal growth factor alpha, Journal of Cell Biology, 100, 1508–1514.

McKee M. D. , Farach-Carson M. , Butler W. , Hauschka P. and Nanci A. (1993) Ultrastructural immunolocalization of non-collagenous (osteopontin and osteocalcin) palsma (albumin) proteins in rat bone, Journal of Bone and Mineral Research, 8, 485–496.

Meilde M. C. , Bord S. , Hembry R. M. , Compston J. , Croucher P. and Reynolds J. J. (1992) Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines, Journal of Cell Science, 103, 1093–1099

Mundy G. (1994) Peptides and growth regulatory factors in bone, Rheumatic Disease Clinics of North America, 20, 577–588.

Mundy G. , Rodan S. B , Majeska R. J. , DeMartino S. , Martin Trimmer, C. , Rodan T. G. A. (1982) Unidirectional migration of osteosarcoma cells with osteoblast characteristics in response to products of bone resorption, Calcified Tissue International, 34, 542–546.

Parfitt A. M. (1982) The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis, Metabolic Bone Disease Related Research, 4, 1–6.

Pfeilschifter J. and Mundy G. R. (1987) TGFB stimulates osteoblast activity and is released during the bone resoprtion process, Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects, 9, 450–454.

Pfeilschifter J. , Bonewald L. and Mundy G. R. (1990a) Characterization of latent transforming beta complex in bone, Journal of Bone and Mineral Research, 5, 49–58.

Pfeilschifter J. , Wolf O. , Naumann A. , Minne H. W. , Mundy G. R. and Ziegler R. (1990) Chemotatic response of osteoblast-like cells to transforming growth factor beta, Journal of Bone and Mineral Research, 5, 825–830.

Roberts A. B. , Anzano M. A. and Wakefield L. M. (1985) Type beta transforming growth factor: a bifunctional regulator of cellular growth, Proceedings of the National Academy of Science U.S.A., 82, 119–123.

Roodman G. D. (1996) Advances in bone biology: the osteoclast, Endocrine Reviews, 17, 308–332

Rudnick M. A. , Schnegelsberg P. N. , Stead R. H. , Braun T. , Arnold H. H. and Jaenisch R. (1993) Myo D or Myf-5 is required for the formation of skeletal muscle, Cell, 75, 1351–1359.

Sly W. S. , Whyte M. , Sundaram V. , Tashian R. , Hewett D. , Guibaud P. , Vainsel M. , Baluarte H. , Gruskin A. , Al-Mosawi M. , Sakati N. and Ohlsson A. (1985) Carbonic anhydrase II deficiency in 12 families with autosomal recessive syndrome of osteoporosis with renal tubular acidosis and cerebral calcification, New England Journal of Medicine, 313, 139–145.

Suda T. , Udagawa N. and Takahashi N. (1996) Cells of bone: osteoclast generation. In: Principles of Bone Biology, Bilezikian J. P. , Raisz L. G. and Rodan G.A. (eds), pp.87-102, Academic Press, San Diego.

Walker D. (1973) Osteoporosis cured by temporary parabiosis, Science, 180, 875–880.

Zaidi M. (1990) ‘Calcium receptors’ on eukaryotic cells with special reference to the osteoclast, Bioscience Reports, 10, 493–507.